DE69208104T2 - Orale, osmotische vorrichtung - Google Patents

Orale, osmotische vorrichtung

Info

Publication number
DE69208104T2
DE69208104T2 DE69208104T DE69208104T DE69208104T2 DE 69208104 T2 DE69208104 T2 DE 69208104T2 DE 69208104 T DE69208104 T DE 69208104T DE 69208104 T DE69208104 T DE 69208104T DE 69208104 T2 DE69208104 T2 DE 69208104T2
Authority
DE
Germany
Prior art keywords
wall
support material
fibrous support
mouth
passage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69208104T
Other languages
English (en)
Other versions
DE69208104D1 (de
Inventor
David Emil Edgren
Gurdish Kaur Bhatti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of DE69208104D1 publication Critical patent/DE69208104D1/de
Application granted granted Critical
Publication of DE69208104T2 publication Critical patent/DE69208104T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
DE69208104T 1991-12-18 1992-12-18 Orale, osmotische vorrichtung Expired - Fee Related DE69208104T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/809,741 US5200194A (en) 1991-12-18 1991-12-18 Oral osmotic device
PCT/US1992/011130 WO1993011748A1 (en) 1991-12-18 1992-12-18 Oral osmotic device

Publications (2)

Publication Number Publication Date
DE69208104D1 DE69208104D1 (de) 1996-03-14
DE69208104T2 true DE69208104T2 (de) 1996-05-30

Family

ID=25202119

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69208104T Expired - Fee Related DE69208104T2 (de) 1991-12-18 1992-12-18 Orale, osmotische vorrichtung

Country Status (11)

Country Link
US (1) US5200194A (de)
EP (1) EP0617611B1 (de)
JP (1) JPH07506806A (de)
AT (1) ATE133561T1 (de)
AU (1) AU3333393A (de)
DE (1) DE69208104T2 (de)
DK (1) DK0617611T3 (de)
ES (1) ES2082626T3 (de)
MX (1) MX9207402A (de)
WO (1) WO1993011748A1 (de)
ZA (1) ZA929848B (de)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
AU691376B2 (en) * 1994-12-05 1998-05-14 Pauli, Gunter Method of drug delivery and coatings for use in the method
US5958450A (en) * 1994-12-05 1999-09-28 Phillip Peatey & Gunter Pauli Method of drug delivery and coated oral dosage forms for use in the method
US5772640A (en) * 1996-01-05 1998-06-30 The Trustees Of Columbia University Of The City Of New York Triclosan-containing medical devices
WO1997006696A1 (en) * 1995-08-15 1997-02-27 Robert Eric Montgomery Improved proteinaceous animal chew with dentally therapeutic cation
FR2747570B1 (fr) * 1996-04-19 1998-07-24 Dogself Composition a effet antitartre et son utilisation dans des complements alimentaires pour animaux
US6030358A (en) * 1997-08-08 2000-02-29 Odland; Rick Matthew Microcatheter and method for site specific therapy
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
JP3718341B2 (ja) 1998-05-12 2005-11-24 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースとその製造方法
DK1561458T3 (da) * 1998-07-28 2010-10-25 Takeda Pharmaceutical Hurtigt henfaldende fast middel
US6224579B1 (en) 1999-03-31 2001-05-01 The Trustees Of Columbia University In The City Of New York Triclosan and silver compound containing medical devices
US6319510B1 (en) 1999-04-20 2001-11-20 Alayne Yates Gum pad for delivery of medication to mucosal tissues
EP1054019A1 (de) * 1999-05-18 2000-11-22 Shin-Etsu Chemical Co., Ltd. Niedersubstituierte Hydroxypropylcellulose
US20040215129A1 (en) * 1999-09-16 2004-10-28 Gambro Ab Method and cycler for the administration of a peritoneal dialysis fluid
US6680069B1 (en) 1999-11-09 2004-01-20 Shin-Etsu Chemical Co., Ltd. Low-substituted hydroxypropyl cellulose and process for manufacturing the same
JP3552160B2 (ja) 2000-01-14 2004-08-11 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース粒子の形成方法
US6770297B1 (en) * 2000-05-26 2004-08-03 Unitech Pharmaceuticals, Inc. Controlled release delivery system of solid dosage form
JP3595765B2 (ja) * 2000-09-27 2004-12-02 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースを含む乾式直打用基剤
US7329412B2 (en) * 2000-12-22 2008-02-12 The Trustees Of Columbia University In The City Of New York Antimicrobial medical devices containing chlorhexidine free base and salt
JP4675027B2 (ja) * 2001-04-20 2011-04-20 株式会社札幌イムノ・ダイアグノスティック・ラボラトリー 口腔内分泌液の採取兼回収器具
FR2823974B1 (fr) * 2001-04-25 2004-10-15 Pf Medicament Pastille medicamenteuse a liberation lente du principe actif
EP1438028A1 (de) * 2001-09-28 2004-07-21 McNEIL-PPC, INC. Dosierformen mit modifizierter freisetzung
US7491407B2 (en) * 2001-10-31 2009-02-17 North Carolina State University Fiber-based nano drug delivery systems (NDDS)
US7328706B2 (en) * 2002-05-06 2008-02-12 Dynamic Mouth Devices Llc Therapeutic and protective dental device useful as an intra-oral delivery system
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US20040208908A1 (en) * 2003-04-16 2004-10-21 The Trustees Of Columbia University In The City Of New York Antimicrobial medical articles containing a synergistic combination of anti-infective compounds and octoxyglycerin
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
US20060095021A1 (en) * 2004-11-02 2006-05-04 Casas-Bejar Jesus W Introduction of agent with medical device
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
MX2008001520A (es) * 2005-08-01 2008-04-07 Teva Pharma Composiciones de tizanidina y metodos de tratamiento usando las composiciones.
US20070048347A1 (en) 2005-08-26 2007-03-01 Laura Bardach Intra-oral device for treating obesity
WO2007026864A1 (ja) * 2005-09-01 2007-03-08 Eisai R & D Management Co., Ltd. 崩壊性の改善された医薬組成物の製造方法
WO2007070795A2 (en) * 2005-12-12 2007-06-21 The Trustees Of Columbia University In The City Of New York Broad spectrum non-traditional preservative system
US20080044797A1 (en) * 2006-08-15 2008-02-21 Laura Bardach Inserts for use with oral appliances
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
WO2008067485A1 (en) * 2006-11-30 2008-06-05 Accu-Break Technologies, Inc. Divisible osmotic dosage forms and methods of use
US9687429B2 (en) * 2007-06-20 2017-06-27 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing low concentrations of botanicals
US9981069B2 (en) 2007-06-20 2018-05-29 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
WO2008157092A1 (en) * 2007-06-20 2008-12-24 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US20090035228A1 (en) * 2007-08-02 2009-02-05 Shanta Modak Skin and surface disinfectant compositions containing botanicals
US9511040B2 (en) 2007-06-20 2016-12-06 The Trustees Of Columbia University In The City Of New York Skin and surface disinfectant compositions containing botanicals
US20100172848A1 (en) * 2008-08-01 2010-07-08 The Trustees Of Columbia University In The City Of New York Skin and surface disinfectant compositions containing botanicals
JP2012533585A (ja) 2009-07-22 2012-12-27 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 酸化感受性オピオイドのための不正使用防止剤形
WO2012028319A1 (en) 2010-09-02 2012-03-08 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
AU2012246490B2 (en) 2011-04-18 2016-08-04 Eisai R&D Management Co., Ltd. Therapeutic agent for tumor
EP2714937B1 (de) 2011-06-03 2018-11-14 Eisai R&D Management Co., Ltd. Biomarker zur vorhersage und beurteilung des ansprechens von schilddrüsen- und nierenkrebspatienten auf lenvatinibverbindungen
CN103857386A (zh) 2011-07-29 2014-06-11 格吕伦塔尔有限公司 提供药物立即释放的抗破碎片剂
BR112014002022A2 (pt) 2011-07-29 2017-02-21 Gruenenthal Gmbh comprimido resistente à violação proporcionando liberação de fármaco imediata
EP2773334B1 (de) 2011-11-03 2019-08-28 The Trustees of Columbia University in the City of New York Zusammensetzung mit verzögerter antimikrobieller wirkung
US9968101B2 (en) 2011-11-03 2018-05-15 The Trustees Of Columbia University In The City Of New York Botanical antimicrobial compositions
TW201330856A (zh) 2011-12-06 2013-08-01 Univ Columbia 廣效性的天然防腐組成物
AU2013248351B2 (en) 2012-04-18 2018-04-26 Grunenthal Gmbh Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US9074972B2 (en) 2012-05-16 2015-07-07 Dionex Corporation Surrogate addition device and a method of analyte concentration
US9499941B2 (en) 2012-05-25 2016-11-22 Kimberly-Clark Worldwide, Inc. High strength macroalgae pulps
US8574400B1 (en) 2012-05-25 2013-11-05 Kimberly-Clark Worldwide, Inc. Tissue comprising macroalgae
MX2015004979A (es) 2012-12-21 2015-07-17 Eisai R&D Man Co Ltd Forma amorfa de derivado de quinolina y metodo para su produccion.
CA2912219C (en) 2013-05-14 2021-11-16 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
BR112015026549A2 (pt) 2013-05-29 2017-07-25 Gruenenthal Gmbh forma de dosagem à prova de violação contendo uma ou mais partículas
US9074324B2 (en) 2013-06-10 2015-07-07 Kimberly-Clark Worldwide, Inc. Layered tissue structures comprising macroalgae
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
CA2931553C (en) 2013-11-26 2022-01-18 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
AU2015309862C1 (en) 2014-08-28 2020-10-15 Eisai R&D Management Co., Ltd. High-purity quinoline derivative and method for manufacturing same
RU2017128583A (ru) 2015-02-25 2019-03-25 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Способ ослабления горечи хинолинового производного
WO2016140717A1 (en) 2015-03-04 2016-09-09 Merck Sharp & Dohme Corp. Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
US10575976B2 (en) 2015-04-30 2020-03-03 Dynamic Mouth Devices, L.L.C. Method and apparatus for weight management utilizing an intra-oral device
EP3311841B1 (de) 2015-06-16 2021-07-28 PRISM BioLab Co., Ltd. Antikrebsmittel
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
CN110859997B (zh) * 2018-12-20 2020-06-23 四川大学 具有成骨-抗炎-血糖三维响应结构的牙种植体及其制备方法
US10758329B1 (en) 2019-08-20 2020-09-01 Raymond L. Wright, III Hydrating mouth guard

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3173876A (en) * 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
NL271831A (de) * 1960-11-29
US3276586A (en) * 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
US3546142A (en) * 1967-01-19 1970-12-08 Amicon Corp Polyelectrolyte structures
US3541006A (en) * 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) * 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4568535A (en) * 1982-08-06 1986-02-04 Loesche Walter J Composition for periodontal administration
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US5021053A (en) * 1989-07-14 1991-06-04 Alza Corporation Oral osmotic device with hydrogel driving member
ZA915648B (en) * 1990-07-23 1992-05-27 Alza Corp Oral osmotic device for delivering nicotine

Also Published As

Publication number Publication date
US5200194A (en) 1993-04-06
DE69208104D1 (de) 1996-03-14
ZA929848B (en) 1994-01-13
AU3333393A (en) 1993-07-19
DK0617611T3 (da) 1996-05-20
EP0617611A1 (de) 1994-10-05
MX9207402A (es) 1993-07-01
ES2082626T3 (es) 1996-03-16
WO1993011748A1 (en) 1993-06-24
JPH07506806A (ja) 1995-07-27
ATE133561T1 (de) 1996-02-15
EP0617611B1 (de) 1996-01-31

Similar Documents

Publication Publication Date Title
DE69208104T2 (de) Orale, osmotische vorrichtung
NO915043D0 (no) Osmoseanordning for kontrollert avgivelse av et nyttig middel
FI940866A0 (fi) pH-herkällä laukaisimella varustetut, osmoottiset, hajoavat laitteet aineen vapauttamiseksi
EP1138275A3 (de) Gerät zum Versprühen mehrerer Flüssigkeiten
DE59509755D1 (de) Implantat und applikationsvorrichtung
WO2003009882A3 (en) Local concentration management system
SE9102539L (sv) Faestningsanordning
ATE111351T1 (de) Oral anzuwendende osmotische vorrichtung zur abgabe von nicotin.
ES2077757T5 (es) Preparacion farmaceutica solida con disolucion rapida que contiene la n-acetilcisteina.
GR3001893T3 (en) 2 stage drug delivery device
SE9703925D0 (sv) Slanganordning samtanvändning därav
JPH0576417U (ja) 治療器具消毒装置
SE0203590D0 (sv) Medicinsk anordning

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee